Due Diligence of course...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GSK and THRX Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of ... http://finance.yahoo.com/news/gsk-theravance-announce-positive-data-114000832.html?soc_src=mediacontentstory via @YahooFinance
PTLA Portola Pharmaceuticals Announces Positive Phase 2 Data With FDA-Designated Breakthrough Therapy ... http://finance.yahoo.com/news/portola-pharmaceuticals-announces-positive-phase-120000662.html?soc_src=mediacontentstory via @YahooFinance
NWBO DCVAX-DIRECT TRIAL UPDATE INDICATES FURTHER POSITIVE RESPONSES; 3 CASE STUDIES SHOW NO LIVE TUMOR... http://finance.yahoo.com/news/dcvax-direct-trial-indicates-further-121500060.html?soc_src=mediacontentstory via @YahooFinance
ATNM Panelists at NewYorkBIO-CONference Highlight Prior Clinical Data Showing Iomabâ„¢-B Improves Surviv... http://finance.yahoo.com/news/panelists-newyorkbio-conference-highlight-prior-131500692.html?soc_src=mediacontentstory via @YahooFinance
WeedStock Conference June 29 through July 1 at the Westin Denver Downtown in Denver, Colorado
http://www.weedstockconference.com/presenters.html
AGIO Agios Pharmaceuticals Initiates Multiple Ascending Dose Trial in Healthy Volunteers of AG-348 for... http://finance.yahoo.com/news/agios-pharmaceuticals-initiates-multiple-ascending-120000669.html?soc_src=mediacontentstory
ADXS Advaxis Announces Business Update Conference Call FOR TOMORROW http://finance.yahoo.com/news/advaxis-announces-business-conference-call-113000255.html?soc_src=mediacontentstory
ALNY Alnylam Presents New Pre-Clinical Data with Development Candidate for ALN-CC5, a Subcutaneously A... http://finance.yahoo.com/news/alnylam-presents-pre-clinical-data-120000567.html?soc_src=mediacontentstory
GLMD Galmed Pharmaceuticals Announces the Filing of a Provisional Patent Application for the Use of Ar... http://finance.yahoo.com/news/galmed-pharmaceuticals-announces-filing-provisional-120000264.html?soc_src=mediacontentstory
Merck (MRK) surprised many folks Monday morning by announcing plans to acquire Idenix Pharmaceuticals (IDIX) for $3.85 billion.
IMMU Immunomedics Announces Orphan Drug Designation for IMMU-132 for Pancreatic Cancer Therapy http://finance.yahoo.com/news/immunomedics-announces-orphan-drug-designation-123000043.html?soc_src=mediacontentstory
CBST Cubist Announces Publication of Pivotal Data from SIVEXTROâ„¢ (tedizolid phosphate) ESTABLISH-2 Cli... http://finance.yahoo.com/news/cubist-announces-publication-pivotal-data-130000074.html?soc_src=mediacontentstory
TTHI Transition Therapeutics Enters Into a Private Placement with Investors to Receive up to US$30.8 M... http://finance.yahoo.com/news/transition-therapeutics-enters-private-placement-130100657.html?soc_src=mediacontentstory
gm TraderX, 147 to u:)
#95 to you SRH :)
#115 for you:) cheer's
ADXS Advaxis's ADXS-cHER2 Immunotherapy Continues to Demonstrate Significantly Prolonged Survival in C... http://finance.yahoo.com/news/advaxiss-adxs-cher2-immunotherapy-continues-113000712.html?soc_src=mediacontentstory
BCLI First Patient Enrolled in BrainStorm's Phase II ALS Trial at Massachusetts General Hospital http://finance.yahoo.com/news/first-patient-enrolled-brainstorms-phase-124000617.html?soc_src=mediacontentstory
IBIO iBio European Patent on iBioModulator Technology Emerges From Opposition Period http://finance.yahoo.com/news/ibio-european-patent-ibiomodulator-technology-123100769.html?soc_src=mediacontentstory
CRIS Curis Announces Re-Initiation of Patient Dosing in CUDC-427 Monotherapy Clinical Trial http://finance.yahoo.com/news/curis-announces-initiation-patient-dosing-110000940.html?soc_src=mediacontentstory
MRNA Marina Biotech Receives Decision to Grant Japanese Patent for Its SMARTICLES Nucleic Acid Deliver... http://finance.yahoo.com/news/marina-biotech-receives-decision-grant-113000030.html?soc_src=mediacontentstory
MDGN Medgenics Announces First Patient Implanted in Phase 1/2 Clinical Trial of MDGN-201 (EPODURE) http://finance.yahoo.com/news/medgenics-announces-first-patient-implanted-123000537.html?soc_src=mediacontentstory
BHRT Bioheart to Present at the PRP and Regenerative Medicine Symposium (TOBI 2014) http://finance.yahoo.com/news/bioheart-present-prp-regenerative-medicine-120000615.html?soc_src=mediacontentstory
MTST MetaStat, Inc. Announces Publication of Results of its MetaSite Breast Test in the Journal of the... http://finance.yahoo.com/news/metastat-inc-announces-publication-results-100000387.html?
ADXS Data Published by Researchers at the National Cancer Institute Further Identifies How Advaxis's Lm-LLO Immunotherapy Eradicates Tumors http://finance.yahoo.com/news/data-published-researchers-national-cancer-120000298.html
AVXL Anavex Awarded New U.S. Patent http://finance.yahoo.com/news/anavex-awarded-u-patent-112700867.html?
ARGS Treatment With AGS-003 and Sunitinib Associated With Doubling of Expected Survival in Patients Wi... http://finance.yahoo.com/news/treatment-ags-003-sunitinib-associated-123000861.html?soc_src=mediacontentstory
AQXP Aquinox Pharmaceuticals Announces Expansion of Ongoing Phase 2 Trials of AQX-1125, Including Acce... http://finance.yahoo.com/news/aquinox-pharmaceuticals-announces-expansion-ongoing-123000630.html?soc_src=mediacontentstory
BIOC Biocept Expands Breast Cancer Offering http://finance.yahoo.com/news/biocept-expands-breast-cancer-offering-123000494.html?soc_src=mediacontentstory
ARIA ARIAD Announces Longer-Term Safety and Efficacy Data of Ponatinib from PACE and Phase 1 Clinical ... http://finance.yahoo.com/news/ariad-announces-longer-term-safety-113000953.html?soc_src=mediacontentstory
PLPL Plandai Biotechnology, Inc. Awarded $1.3 Million Grant From South African Department of Trade & I... http://finance.yahoo.com/news/plandai-biotechnology-inc-awarded-1-130000059.html?soc_src=mediacontentstory
IMMU Immunomedics Reports IMMU-130 is Active in Patients With Irinotecan-Refractory Colorectal Cancer http://finance.yahoo.com/news/immunomedics-reports-immu-130-active-123000785.html?soc_src=mediacontentstory
LPTN Lpath to Present Trial-in-Progress Poster at ASCO Describing the ASONEP Phase 2 Clinical Trial in... http://finance.yahoo.com/news/lpath-present-trial-progress-poster-120000597.html?soc_src=mediacontentstory
BCLI Positive Interim Phase IIa ALS Data With BrainStorm's NurOwn Presented at Joint Congress of Europ... http://finance.yahoo.com/news/positive-interim-phase-iia-als-120000240.html?soc_src=mediacontentstory
BTX BioTime's Subsidiary Asterias Biotherapeutics, Inc. Announces a $14.3 Million Strategic Partnersh... http://finance.yahoo.com/news/biotimes-subsidiary-asterias-biotherapeutics-inc-123000881.html?soc_src=mediacontentstory
:( DARA BioSciences, Inc. Announces Pricing of $12.5 Million Public Offering http://finance.yahoo.com/news/dara-biosciences-inc-announces-pricing-124641447.html?soc_src=mediacontentstory
HTBX Heat Biologics Receives Green Light to Expand Enrollment of Its Phase 1/2 Study of HS-410 in Bladder Cancer Based on Encouraging Preliminary Safety Results http://finance.yahoo.com/news/heat-biologics-receives-green-light-120500050.html?soc_src=mediacontentstory
#48 back at ya Street_ ty ty
yayy 400, ty kgreenman, had ya marked:) ty ty
QRXPY QRxPharma Receives Complete Response Letter From FDA Regarding Moxduo® NDA http://finance.yahoo.com/news/qrxpharma-receives-complete-response-letter-100000793.html?soc_src=mediacontentstory